{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:21Z","timestamp":1707524421949},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,5]]},"DOI":"10.7759\/cureus.20953","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T13:47:38Z","timestamp":1641390458000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Diagnostic Utility of the Immunohistochemical Markers in the Accurate Diagnosis of Thyroid Neoplasms: A Retrospective Study in a Tertiary Care Hospital of Pakistan"],"prefix":"10.7759","author":[{"given":"Kaleemullah","family":"Badini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafar","family":"Suchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.10.002","article-title":"Evolving understanding of the epidemiology of thyroid cancer","volume":"48","author":"Seib CD","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 2019, 48:23-35. 10.1016\/j.ecl.2018.10.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2014.04.001","article-title":"Thyroid cancer","volume":"38","author":"Lebastchi AH","year":"2014","unstructured":"Lebastchi AH, Callender GG. Thyroid cancer. Curr Probl Cancer. 2014, 38:48-74. 10.1016\/j.currproblcancer.2014.04.001","journal-title":"Curr Probl Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.10.001","article-title":"The current histologic classification of thyroid cancer","volume":"48","author":"Asa SL","year":"2019","unstructured":"Asa SL. The current histologic classification of thyroid cancer. Endocrinol Metab Clin North Am. 2019, 48:1-22. 10.1016\/j.ecl.2018.10.001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete A","year":"2020","unstructured":"Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol (Lausanne). 2020, 11:102. 10.3389\/fendo.2020.00102","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000486422","article-title":"Heterogeneity of thyroid cancer","volume":"85","author":"Chmielik E","year":"2018","unstructured":"Chmielik E, Rusinek D, Oczko-Wojciechowska M, Jarzab M, Krajewska J, Czarniecka A, Jarzab B. Heterogeneity of thyroid cancer. Pathobiology. 2018, 85:117-29. 10.1159\/000486422","journal-title":"Pathobiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00082","article-title":"New therapies for advanced thyroid Cancer","volume":"11","author":"Laha D","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M. New therapies for advanced thyroid Cancer. Front Endocrinol (Lausanne). 2020, 11:82. 10.3389\/fendo.2020.00082","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-010-9114-y","article-title":"Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19","volume":"21","author":"Barut F","year":"2010","unstructured":"Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, Ozdamar SO. Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol. 2010, 21:80-9. 10.1007\/s12022-010-9114-y","journal-title":"Endocr Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000137128.64978.bc","article-title":"Discrimination of benign and malignant thyroid nodules by molecular profiling","volume":"240","author":"Finley DJ","year":"2004","unstructured":"Finley DJ, Zhu B, Barden CB, Fahey TJ 3rd. Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg. 2004, 240:425-36; discussion 436-7. 10.1097\/01.sla.0000137128.64978.bc","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800705","article-title":"Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining","volume":"19","author":"Nasr MR","year":"2006","unstructured":"Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining. Mod Pathol. 2006, 19:1631-7. 10.1038\/modpathol.3800705","journal-title":"Mod Pathol"},{"key":"ref10","article-title":"Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue","volume":"18","author":"Cvejic D","year":"1998","unstructured":"Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res. 1998, 18:2637-41.","journal-title":"Anticancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000325891","article-title":"Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions","volume":"50","author":"Kim MJ","year":"2006","unstructured":"Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006, 50:28-34. 10.1159\/000325891","journal-title":"Acta Cytol"},{"key":"ref12","article-title":"[Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules]","volume":"27","author":"Wang LH","year":"2005","unstructured":"Wang LH, Zhao YJ, Wang XY, et al.. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules]. Zhonghua Zhong Liu Za Zhi. 2005, 27:547-50.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.09.015","article-title":"Serum thyroglobulin determination in thyroid cancer patients","volume":"22","author":"Francis Z","year":"2008","unstructured":"Francis Z, Schlumberger M. Serum thyroglobulin determination in thyroid cancer patients. Best Pract Res Clin Endocrinol Metab. 2008, 22:1039-46. 10.1016\/j.beem.2008.09.015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref14","article-title":"Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin","volume":"8","author":"Ceyran AB","year":"2015","unstructured":"Ceyran AB, \u015eenol S, \u015eim\u015fek B\u00c7, Sa\u011f\u0131ro\u011flu J, Ayd\u0131n A. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin. Int J Clin Exp Pathol. 2015, 8:3670-80.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1385\/ep:16:4:295","article-title":"The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid","volume":"16","author":"Asa SL","year":"2005","unstructured":"Asa SL. The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid. Endocr Pathol. 2005, 16:295-309. 10.1385\/ep:16:4:295","journal-title":"Endocr Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1042\/CS20080068","article-title":"Thyroid transcription factor-1 (TTF-1\/Nkx2.1\/TITF1) gene regulation in the lung","volume":"116","author":"Boggaram V","year":"2009","unstructured":"Boggaram V. Thyroid transcription factor-1 (TTF-1\/Nkx2.1\/TITF1) gene regulation in the lung. Clin Sci (Lond). 2009, 116:27-35. 10.1042\/CS20080068","journal-title":"Clin Sci (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.07.027","article-title":"Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study","volume":"82","author":"Deeken-Draisey A","year":"2018","unstructured":"Deeken-Draisey A, Yang GY, Gao J, Alexiev BA. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol. 2018, 82:140-8. 10.1016\/j.humpath.2018.07.027","journal-title":"Hum Pathol"},{"key":"ref18","unstructured":"Cytokeratin AE1\/AE3. (2003). Accessed. January 05, 2022: https:\/\/propath.com\/cytokeratin-ae1-ae3\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15967.1","article-title":"Vimentin on the move:\u00a0new developments in cell migration","volume":"7","author":"Battaglia RA","year":"2018","unstructured":"Battaglia RA, Delic S, Herrmann H, Snider NT. Vimentin on the move:\u00a0new developments in cell migration. F1000Res. 2018, 7:10.12688\/f1000research.15967.1","journal-title":"F1000Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134675","article-title":"Vimentin as a multifaceted player and potential therapeutic target in viral infections","volume":"21","author":"Ramos I","year":"2020","unstructured":"Ramos I, Stamatakis K, Oeste CL, P\u00e9rez-Sala D. Vimentin as a multifaceted player and potential therapeutic target in viral infections. Int J Mol Sci. 2020, 21:10.3390\/ijms21134675","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2019.01.001","article-title":"CD3+CD20+ T cells and their roles in human diseases","volume":"80","author":"Chen Q","year":"2019","unstructured":"Chen Q, Yuan S, Sun H, Peng L. CD3+CD20+ T cells and their roles in human diseases. Hum Immunol. 2019, 80:191-4. 10.1016\/j.humimm.2019.01.001","journal-title":"Hum Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80776-evaluation-of-diagnostic-utility-of-the-immunohistochemical-markers-in-the-accurate-diagnosis-of-thyroid-neoplasms-a-retrospective-study-in-a-tertiary-care-hospital-of-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:24Z","timestamp":1707507324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80776-evaluation-of-diagnostic-utility-of-the-immunohistochemical-markers-in-the-accurate-diagnosis-of-thyroid-neoplasms-a-retrospective-study-in-a-tertiary-care-hospital-of-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.20953","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,5]]}}}